Diruthenium Complexes Research Articles

Deciphering the role of neutral diruthenium complexes in protein binding

Deciphering the role of neutral diruthenium complexes in protein binding

Electronically Weakly Coupled 4,4′‐Divinylazoarylenes‐Bridged Diruthenium Complexes Featuring Two Ru(CO)Cl(PiPr3)2 Entities

AbstractWe report here on four novel 4,4′‐divinylazoarylenes‐bridged diruthenium complexes featuring two Ru(CO)Cl(PiPr3)2 entities with a general formula of [{Ru(CO)Cl(PiPr3)2}2(μ‐{CH=CH−Ar}2‐N=N‐4,4′)]; Ar=C6H4; [1 azo], C6H3‐2‐Me; [2 azo], C6H3‐(Me)2‐2,6; [3 azo], and C6H2‐(iPr)2‐2,6; [4 azo]. Those five‐coordinated, square‐pyramidal, 16‐valence electrons (VEs) type‐complexes [1 azo]–[4 azo] were successfully synthesized by the stereo‐and regiospecific insertion of the Ru−H bond of the hydrido substrate HRu(CO)Cl(PiPr3)2 into the two terminal acetylenic bonds of the corresponding 4,4′‐diethynylated azoarylenes [L1]–[L4]. They were routinely characterized in their neutral state by traditional IR, UV/Vis and NMR spectroscopic techniques, and in their two‐closely accessible oxidized states by IR, UV/Vis/NIR spectroelectrochemistry along with electrochemical techniques as well as by (TD)‐DFT calculations. Detailed electrochemical studies on these complexes and IR, UV/Vis/NIR spectro(electro)scopic characterization of their oxidized forms along with (TD)‐DFT calculations revealed to massive 4,4′‐divinylazobenzene linker contributions to the two redox processes in addition to the noteworthy negligible electronic interaction “communication” between the two remote redox‐active end‐groups, rendering them as unique weakly coupled borderline class I/II MV systems in accordance with the Robin and Day classification. Incorporating the four bulky iPr substituents into the ortho‐positions of the 4,4′‐divinylazobenzene linker results to a significant decrease in the tendency of the co‐planarity of the bridge.

Aminocarbyne-Alkyne Coupling in Diruthenium Complexes: Exploring the Anticancer Potential of the Resulting Vinyliminium Complexes and Comparison with Diiron Homologues.

New diruthenium complexes based on the scaffold Ru2Cp2(CO)2 (Cp = η5-C5H5) and containing a bridging vinyliminium ligand, [2a-d]CF3SO3, were synthesized through regioselective coupling of alkynes with an aminocarbyne precursor (85-90% yields). The reaction involving phenylacetylene proceeded with the formation of a diruthenacyclobutene byproduct, [4]CF3SO3 (10% yield). Complexes [2a-d]+ undergo partial alkyne extrusion in contact with alumina or CDCl3. All products were characterized by elemental analysis, infrared and multinuclear NMR spectroscopy, and single crystal X-ray diffraction in two cases. Complexes [2a-d]+ revealed an outstanding stability in DMEM cell culture medium at 37 °C (<1% degradation over 72 h). These complexes exhibited cytotoxicity in human colon colorectal adenocarcinoma HT-29 cells in the low micromolar range, with lower IC50 values than those obtained with the homologous diiron complexes previously reported. Evaluation of ROS (reactive oxygen species) production and O2 consumption rate (OCR) highlighted the higher potential of Ru2 complexes, compared to the Fe2 counterparts, to impact mitochondrial activity, with the heterometallic Ru2-ferrocenyl complex [2d]+ showing the best performance.

Pyrazine-Coordinated Dinuclear and Mononuclear Ruthenium Complexes Formed via the Conversion of the Triply Chlorido-Bridged Diruthenium(II) Complex.

The pyrazine-coordinated dinuclear and mononuclear ruthenium complexes were synthesized through the framework conversion reactions of the triply chlorido-bridged diruthenium(II) complex [{RuII,II(bbpma)}2(μ-Cl)3]+ (bbpma; benzylbis(2-pyridylmethyl)amine, [1]+) in the presence of pyrazine, which could function as the simple molecular multinucleation ligand of metal compounds. A reduction reaction of fac-[RuIIICl3(bbpma)] with zinc in the presence of hydrochloric acid afforded [1]+ in solution, and the following addition of pyrazine (1 equiv) in the solution led to the formation of a singly pyrazine (pz)-bridged diruthenium complex, [{RuII,II(μ-Cl2ZnCl2)(bbpma)}2(μ-pz)] ([2(II,II)(ZnCl2)2]). The stoichiometric two-electron oxidation of [2(II,II)(ZnCl2)2] was successfully proceeded, and a Ru(III)-Ru(III) species, [{RuIII,IIICl2(bbpma)}2(μ-pz)](PF6)2 ([III,III](PF6)2), was isolated. The reaction of [1]+ with excess amounts of pyrazine without hydrochloric acid afforded mononuclear Ru(III) and Ru(II) complexes containing one or two pyrazine, fac-[RuClm(pz)3-m(bbpma)]+ (m = 2; [3]+; m = 1; [4]+). The details of the electrochemical and spectroscopic properties of [1]+-[4]+ in organic and aqueous solutions were discussed.

Overcoming Resistance of Caco-2 Cells to 5-Fluorouracil through Diruthenium Complex Encapsulation in PMMA Nanoparticles.

Drug resistance, one of the main drawbacks in cancer chemotherapy, can be tackled by employing a combination of drugs that target different biological processes in the cell, enhancing the therapeutic efficacy. Herein, we report the synthesis and characterization of a new paddlewheel diruthenium complex that includes 5-fluorouracil (5-FU), a commonly used anticancer drug. This drug was functionalized with a carboxylate group to take advantage of the previously demonstrated release capacity of carboxylate ligands from the diruthenium core. The resulting hydrophobic complex, [Ru2Cl(DPhF)3(5-FUA)] (Ru-5-FUA) (DPhF = N,N'-diphenylformamidinate; 5-FUA = 5-fluorouracil-1-acetate) was subsequently entrapped in poly(methyl methacrylate) (PMMA) nanoparticles (PMMA@Ru-5-FUA) via a reprecipitation method to be transported in biological media. The optimized encapsulation procedure yielded particles with an average size of 81.2 nm, a PDI of 0.11, and a zeta potential of 29.2 mV. The cytotoxicity of the particles was tested in vitro using the human colon carcinoma cell line Caco-2. The IC50 (half maximal inhibitory concentration) of PMMA@Ru-5-FUA (6.08 μM) was just slightly lower than that found for the drug 5-FU (7.64 μM). Most importantly, while cells seemed to have developed drug resistance against 5-FU, PMMA@Ru-5-FUA showed an almost complete lethality at ∼30 μM. Conversely, an analogous diruthenium complex devoid of the 5-FU moiety, [Ru2Cl(DPhF)3(O2CCH3)] (PMMA@RuA), displayed a reduced cytotoxicity at equivalent concentrations. These findings highlight the effect of combining the anticancer properties of 5-FU with those of diruthenium species. This suggests that the distinct modes of action of the two chemical species are crucial for overcoming drug resistance.

The binding of diruthenium (II,III) and dirhodium (II,II) paddlewheel complexes at DNA/RNA nucleobases: Computational evidences of an appreciable selectivity toward the AU base pairs

Multiple medicinal strategies involve modifications of the structure of DNA or RNA, which disrupt their correct functioning. Metal complexes with medicinal effects, also known as metallodrugs, are among the agents intended specifically for the attack onto nucleosides. The diruthenium (II,III) and dirhodium (II,II) paddlewheel complexes constitute promising dual acting drugs due to their ability to release the therapeutically active bridging ligands upon their substitution by endogenous ligands. In this paper, we study the structure and the stability of the complexes formed by the diruthenium (II,III) and dirhodium (II,II) paddlewheel complexes coordinated in axial positions with the DNA/RNA nucleobases or base pairs, assuming the attainable metalation at all the accessible pyridyl nitrogens. Dirhodium complexes coordinate at the pyridyl nitrogens more strongly than the diruthenium complexes. On the other hand, we found that the diruthenium scaffold binds more selectively to nucleobase targets. Furthermore, we reveal a tighter coordination of diruthenium complex at the adenine-uracil base pair, compared to adenine-thymine, hence constituting a scarce instance of RNA-selectivity. We envision that the here reported computational outcomes may pace future experiments addressing the binding of diruthenium and dirhodium paddlewheel complexes at either single nucleobases or DNA/RNA fragments.

3,6‐Divinyl‐N‐arylcarbazoles‐bridged diruthenium complexes bearing two Ru(CO)Cl(PiPr3)2 moieties: Polyelectrochromism and electronic coupling

A series of five 3,6‐divinyl‐N‐arylcarbazoles‐bridged diruthenium complexes with a general formula of [{Ru(CO)Cl(PiPr3)2}2(μ‐(CH=CH)2‐(N‐arylcarbazole)‐3,6); aryl = 4‐anisyl; [1a], 4‐tolyl; [1b], phenyl; [1c], 4‐(trifluoromethyl)phenyl; [1d], and 4‐nitrophenyl; [1e]] were successfully synthesized. These new square‐pyramidal bis(ruthenium‐vinyl)‐type complexes were characterized in their neutral state via classical NMR, UV/Vis, and IR spectroscopic techniques and in their three various accessible oxidized states via electrochemical techniques and ESR spectroscopy along with UV/Vis/NIR and IR spectroelectrochemistry as well as with DFT calculations. Our obtained results were compared with the closely related bis(ruthenium‐vinyl)‐appended N‐(4‐anisyl)diphenylamine TAARu2 counterpart of [1a]. Electrochemical studies on complexes [1a]–[1e] revealed three consecutive, chemically and electrochemically, well‐separated, reversible one‐electron oxidation processes at low and well‐accessible potentials. Their half‐wave potential separations ΔE½ between the individual redox waves and the derived comproportionation constants Kc1–Kc3 attribute to noteworthy stability of every oxidized intermediate state. The concert electrochemical and UV/Vis/NIR/IR spectro(electro)scopic results on these rotationally restricted N‐arylcarbazoles‐bridged bis(ruthenium‐alkenyl)‐type complexes [1a]–[1e] confirmed the relative weakness influence of altering the para‐substituent on the peripheral aryl ring. This is most probably due to the sizable torsion with nearly 55° between the co‐planarity of the carbazole heterocycle core and the peripheral N‐bound aryl ring. In their mixed‐valent (MV) radical states [1a]+–[1e]+, the observed pattern of two well‐separated Ru(C≡O) bands mirrors the uneven distribution of the uni‐positive charge over the two chemically equivalent bis(ruthenium‐vinyl) moieties as indicated by classical class II of Robin–Day classification of MV states.

Comparative Analysis of the Inhibitory Mechanism of Aβ1-42 Aggregation by Diruthenium Complexes.

There is a growing interest in the search for metal-based therapeutics for protein misfolding disorders such as Alzheimer's disease (AD). A novel and largely unexplored class of metallodrugs is constituted by paddlewheel diruthenium complexes, which exhibit unusual water solubility and stability and unique coordination modes to proteins. Here, we investigate the ability of the complexes [Ru2Cl(DPhF)(O2CCH3)3]·H2O (1), [Ru2Cl(DPhF)2(O2CCH3)2]·H2O (2), and K2[Ru2(DPhF)(CO3)3]·3H2O (3) (DPhF- = N,N'-diphenylformamidinate) to interfere with the amyloid aggregation of the Aβ1-42 peptide. These compounds differ in charge and steric hindrance due to the coordination of a different number of bulky ligands. The mechanisms of action of the three complexes were studied by employing a plethora of physicochemical and biophysical techniques as well as cellular assays. All these studies converge on different mechanisms of inhibition of amyloid fibrillation: complexes 1 and 2 show a clear inhibitory effect due to an exchange ligand process in the Ru2 unit aided by aromatic interactions. Complex 3 shows no inhibition of aggregation, probably due to its negative charge in solution. This study demonstrates that slight variations in the ligands surrounding the bimetallic core can modulate the amyloid aggregation inhibition and supports the use of paddlewheel diruthenium complexes as promising therapeutics for Alzheimer's disease.

Computational Analysis of Low Overpotential Ammonia Oxidation by Metal-Metal Bonded Ruthenium Catalysts, and Predictions for Related Osmium Catalysts.

The catalyzed electrochemical oxidation of ammonia to nitrogen (AOR) is an important fuel-cell half-reaction that underpins a future nitrogen-based energy economy. Our laboratory has reported spontaneous chemical and electrochemical oxidation of ammonia to dinitrogen via reaction of ammonia with the metal-metal bonded diruthenium complex Ru2(chp)4OTf (chp- = 2-chloro-6-hydroxypyridinate, TfO- = trifluoromethanesulfonate). This complex facilitates electrocatalytic ammonia oxidation at mild applied potentials of -255 mV vs ferrocene, which is the [Ru2(chp)4(NH3)]0/+ redox potential. We now report a comprehensive computational investigation of possible mechanisms for this reaction and electronic structure analysis of key intermediates therein. We extend this analysis to proposed second-generation electrocatalysts bearing structurally similar fhp and hmp (2-fluoro-6-hydroxypyridinate and 2-hydroxy-6-methylpyridinate, respectively) equatorial ligands, and we further expand this study from Ru2 to analogous Os2 cores. Predicted M24+/5+ redox potentials, which we expect to correlate with experimental AOR overpotential, depend strongly on the identity of the metal center, and to a lesser degree on the nature of the equatorial supporting ligand. Os2 complexes are easier to oxidize than analogous Ru2 complexes by ∼640 mV, on average. In contrast to mono-Ru catalysts, which oxidize ammonia via a rate-limiting activation of the strong N-H bond, we find lowest-energy reaction pathways for Ru2 and Os2 complexes that involve direct N-N bond formation onto electrophilic intermediates having terminal amido, imido, or nitrido groups. While transition state energies for Os2 complexes are high, those for Ru2 complexes are moderate and notably lower than those for mono-Ru complexes. We attribute these lower barriers to enhanced electrophilicity of the Ru2 intermediates, which is a consequence of their metal-metal bonded structure. Os2 intermediates are found to be, surprisingly, less electrophilic, and we suggest that Os2 complexes may require access to oxidation states higher than Os25+ in order to perform AOR at reasonable reaction rates.

The influence of phosphine ligands on the redox properties of 1,4-divinylanthrylene-bridged diruthenium complexes and a derived macrocyclic analog

We report on a series of dinuclear 1,4-divinylanthrylene-bridged diruthenium complexes 1A-Ru-PR3 with different phosphine ligands (PiPr3, PiPr2Me, PPh3, and PMe3) and with coordination numbers of five or six. All compounds were characterized by NMR spectroscopy, high resolution ESI-MS and, in the case of 1A-Ru-PiPr3 and 1A-Ru-PMe3, single crystal X-ray diffraction. Cyclic voltammetry measurements reveal that the PR3 ligands, besides tuning the redox potentials, exert a strong influence on the stability of their one- and two-electron oxidized forms. Information on the charge- and spin-density distribution was obtained by IR, UV/Vis/NIR and EPR spectroscopy. Our results indicate full charge and spin delocalization in 1A-Ru-PiPr3•+, 1A-Ru-PMe3•+ and macrocyclic, isophthalate-bridged 2A-Ru-PiPr2Me••2+, whereas 1A-Ru-PiPr2Me•+ constitutes a peculiar case, where valence-delocalized and valence-localized structures seem to coexist.

Diruthenium complexes incorporating carboxylated chalcones with phenyl or ferrocenyl units: Synthesis, structural, electrochemical and DNA binding studies

A total of eight diruthenium sawhorse and cationic complexes incorporating carboxylated chalcones with phenyl or ferrocenyl units have been synthesized and characterized. The electrochemical behavior of the sawhorse and cationic complexes incorporating the ferrocenyl moiety have been studied by cyclic voltammetry. For the cationic complexes both the diruthenium core and the ferrocenyl unit undergo oxidation, in contrast only the ferrocenyl moieties for the sawhorse complexes were oxidized. The enhanced solubility of the cationic complexes over the neutral sawhorse compounds in aqueous medium enabled DNA binding studies to be undertaken for the former. All of the cationic complexes could bind to DNA, and displayed better selectivity for quadruplex over duplex DNA. These results indicate that diruthenium cationic complexes are able to bind to quadruplex DNA and have the potential to function as telomerase inhibitors.

Post-synthetic molecular modifications based on Schiff base condensation reactions for designing functional paddlewheel diruthenium(II,II) complexes.

A new synthetic route for constructing functional paddlewheel diruthenium(II,II) complexes ([RuII,II2]) was developed by utilizing Schiff base condensation reactions of formyl-substituted benzoate-bridged [RuII,II2] complexes with various aromatic monoamines under mild conditions. Cyclic voltammetry and DFT calculations revealed that the attached Schiff base groups significantly affected the electronic states of the resulting [RuII,II2] complexes.

Detailed mechanism of DNA/RNA nucleobase substituting bridging ligand in diruthenium (II,III) and dirhodium (II,II) tetraacetato paddlewheel complexes: Protonation of the leaving acetate is crucial

Paddlewheel complexes of bimetallic scaffolds are emerging metallic agents in the bioinorganic chemistry landscape. In the most commonly employed construct, these complexes are decorated by carboxylate moiety, prompting their possible...

Superior electrocatalytic hydrogen evolution activity of a triply bridged diruthenium(II) complex on a carbon cloth support.

This article describes the structural authentication of a unique triply bridged [1](ClO4)2 and monomeric [2]ClO4/[3]ClO4. Electrochemical HER on a carbon cloth support demonstrated the superior performance of [1](ClO4)2 with high TON (>105) and its long-term stability. The primary kinetic isotope effect of [1](ClO4)2 revealed the involvement of PCET in the rate-determining step.

Intrinsically Chiral Paddlewheel Diruthenium Complexes

A family of heteroleptic paddlewheel diruthenium complexes has been designed to obtain a chiral arrangement of the donor atoms of their equatorial ligands around the metal-metal bond axis. In order...

A new family of thiolate-bridged bimetallic complexes featuring a benzimidazole moiety: synthesis, structure and redox reactivity.

Thiolate-bridged bimetallic complexes have attracted considerable attention owing to their extensive applications in bioinspired catalysis as biological metalloenzymes. Compared with bimetallic complexes supported by common thiolate ligands, those featuring functional groups that may adopt different patterns to coordinate to the metal centers are usually difficult to access, limiting their exploration. The benzimidazole moiety is a multi-faceted functional group; for example, it can act as a biomolecule-responsive ligand for the development of transition metal complexes with anticancer and antitumor properties. However, so far, there has been no report on thiolate-bridged bimetallic complexes featuring a benzimidazole moiety as the functional group. In this work, we use half-sandwich type monometallic (iron, cobalt or ruthenium) complexes as precursors to synthesize a series of thiolate-bridged bimetallic complexes via reactions with benzimidazolylmethyl disulfide (bzmds) and benzimidazol-2-ylmethanethiol (bzmt). X-ray crystallographic analyses show that diiron and dicobalt complexes feature two bzmt ligands in a syn configuration, which are bridged to the two MIII centers through the sulfur and nitrogen atoms. In contrast, the diruthenium complex possesses syn- and anti-configuration isomers in both solution- and solid-state, and the corresponding ratio of the two isomers varies upon employing different solvents. Electrochemical studies reveal that these complexes possess two or more redox couples. In particular, an FeIIIFeIII complex can undergo one-electron reduction to give an isolable FeIIFeIII species. In addition, we investigated their electronic structures by UV/vis spectroscopy and density functional theory (DFT).

A Diruthenium Metallodrug as a Potent Inhibitor of Amyloid-β Aggregation: Synergism of Mechanisms of Action.

The physical and chemical properties of paddlewheel diruthenium compounds are highly dependent on the nature of the ligands surrounding the bimetallic core. Herein, we compare the ability of two diruthenium compounds, [Ru2Cl(D-p-FPhF)(O2CCH3)3]·H2O (1) (D-p-FPhF- = N,N'-bis(4-fluorophenyl)formamidinate) and K3[Ru2(O2CO)4]·3H2O (2), to act as inhibitors of amyloid aggregation of the Aβ1-42 peptide and its peculiar fragments, Aβ1-16 and Aβ21-40. A wide range of biophysical techniques has been used to determine the inhibition capacity against aggregation and the possible mechanism of action of these compounds (Thioflavin T fluorescence and autofluorescence assays, UV-vis absorption spectroscopy, circular dichroism, nuclear magnetic resonance, mass spectrometry, and electron scanning microscopy). Data show that the most effective inhibitory effect is shown for compound 1. This compound inhibits fiber formation and completely abolishes the cytotoxicity of Aβ1-42. The antiaggregatory capacity of this complex can be explained by a binding mechanism of the dimetallic units to the peptide chain along with π-π interactions between the formamidinate ligand and the aromatic side chains. The results suggest the potential use of paddlewheel diruthenium complexes as neurodrugs and confirm the importance of the steric and charge effects on the properties of diruthenium compounds.

Diruthenium Complexes with π-Extended Bridging Bis(alkenyl)arylene Ligands, A Derived Metallamacrocycle, and Their Oxidized Forms

Diruthenium Complexes with π-Extended Bridging Bis(alkenyl)arylene Ligands, A Derived Metallamacrocycle, and Their Oxidized Forms

In vitro antibacterial activity of dinuclear thiolato-bridged ruthenium(II)-arene compounds.

The antibacterial activity of 22 thiolato-bridged dinuclear ruthenium(II)-arene compounds was assessed in vitro against Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus. None of the compounds efficiently inhibited the growth of the three E. coli strains tested, and only compound 5 exhibited a medium activity against this bacterium [MIC (minimum inhibitory concentration) of 25 µM]. However, a significant antibacterial activity was observed against S. pneumoniae, with MIC values ranging from 1.3 to 2.6 µM for compounds 1-3, 5, and 6. Similarly, compounds 2, 5-7, and 20-22 had MIC values ranging from 2.5 to 5 µM against S. aureus. The tested diruthenium compounds have a bactericidal effect significantly faster than that of penicillin. Fluorescence microscopy assays performed on S. aureus using the BODIPY-tagged diruthenium complex 15 showed that this type of metal compound enters the bacteria and does not accumulate in the cell wall of gram-positive bacteria. Cellular internalization was further confirmed by inductively coupled plasma mass spectrometry experiments. The nature of the substituents anchored on the bridging thiols and the compounds molecular weight appears to significantly influence the antibacterial activity. Thus, if overall a decrease of the bactericidal effect with the increase of compounds' molecular weight is observed, however, the complexes bearing larger benzo-fused lactam substituents had low MIC values. This first antibacterial activity screening demonstrated that the thiolato-diruthenium compounds exhibit promising activity against S. aureus and S. pneumoniae and deserve to be considered for further studies. IMPORTANCE The in vitro assessment of diruthenium(II)-arene compounds against Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus showed a significant antibacterial activity of some compounds against S. pneumoniae, with minimum inhibitory concentration (MIC) values ranging from 1.3 to 2.6 µM, and a medium activity against E. coli, with MIC of 25 µM. The nature of the substituents anchored on the bridging thiols and the compounds molecular weight appear to significantly influence the antibacterial activity. Fluorescence microscopy showed that these ruthenium compounds enter the bacteria and do not accumulate in the cell wall of gram-positive bacteria. These diruthenium(II)-arene compounds exhibit promising activity against S. aureus and S. pneumoniae and deserve to be considered for further studies, especially the compounds bearing larger benzo-fused lactam substituents.

Anticancer Potential of Diruthenium Complexes with Bridging Hydrocarbyl Ligands from Bioactive Alkynols.

Diruthenacyclopentenone complexes of the general composition [Ru2Cp2(CO)2{μ-η1:η3-CH═C(C(OH)(R))C(═O)}] (2a-c; Cp = η5-C5H5) were synthesized in 94-96% yields from the reactions of [Ru2Cp2(CO)2{μ-η1:η3-C(Ph)═C(Ph)C(═O)}] (1) with 1-ethynylcyclopentanol, 17α-ethynylestradiol, and 17-ethynyltestosterone, respectively, in toluene at reflux. Protonation of 2a-c by HBF4 afforded the corresponding allenyl derivatives [Ru2Cp2(CO)3{μ-η1:η2-CH═C═R}]BF4 (3a-c) in 85-93% yields. All products were thoroughly characterized by elemental analysis, mass spectrometry, and IR, UV-vis, and nuclear magnetic resonance spectroscopy. Additionally, 2a and 3a were investigated by cyclic voltammetry, and the single-crystal diffraction method was employed to establish the X-ray structures of 2b and 3a. The cytotoxicity in vitro of 2b and 3a-c was evaluated against nine human cancer cell lines (A2780, A2780R, MCF-7, HOS, A549, PANC-1, Caco-2, PC-3, and HeLa), while the selectivity was assessed on normal human lung fibroblast (MRC-5). Overall, complexes exert stronger cytotoxicity than cisplatin, and 3b (comprising 17α-estradiol derived ligand) emerged as the best-performing complex. Inductively coupled plasma mass spectrometry cellular uptake studies in A2780 cells revealed a higher level of internalization for 3b and 3c compared to 2b, 3a, and the reference compound RAPTA-C. Experiments conducted on A2780 cells demonstrated a noteworthy impact of 3a and 3b on the cell cycle, leading to the majority of the cells being arrested in the G0/G1 phase. Moreover, 3a moderately induced apoptosis and oxidative stress, while 3b triggered autophagy and mitochondrial membrane potential depletion.